Prokineticin Receptor 2 抗体 (AA 121-136)
Quick Overview for Prokineticin Receptor 2 抗体 (AA 121-136) (ABIN5875642)
抗原
See all Prokineticin Receptor 2 (PROKR2) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 121-136
-
纯化方法
- Purified antibody
-
免疫原
- Synthesized peptide fragment of human HH3 (AA: 121-136) expressed in E. Coli.
-
亚型
- IgG1
-
-
anti-Prokineticin Receptor 2 (PROKR2) antibody
PROKR2 适用: 人, 小鼠 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (N-Term) antibodyPROKR2 适用: 人, 猴 IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (Internal Region) antibodyVerified PROKR2 适用: 人, 大鼠 ELISA, WB, IHC 宿主: 山羊 Polyclonal unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (AA 121-136) antibodyPROKR2 适用: 人, 小鼠, 大鼠 ELISA, WB, FACS 宿主: 小鼠 Monoclonal 6D3B9 unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (acetylated) antibodyPROKR2 适用: 人, 小鼠 ELISA, WB, FACS 宿主: 小鼠 Monoclonal 4E9B11 unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (AA 1-45) antibodyPROKR2 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (C-Term) antibodyPROKR2 适用: 人, 猴 IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (N-Term) antibodyPROKR2 适用: 人 ELISA, WB 宿主: 兔 Polyclonal unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (N-Term) antibodyPROKR2 适用: 人 IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Prokineticin Receptor 2 (PROKR2) (C-Term) antibodyPROKR2 适用: 人, 小鼠, 大鼠 ELISA, WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.0 mg/mL
-
缓冲液
- Purified antibody in PBS with 0.05 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
- Prokineticin Receptor 2 (PROKR2)
-
别名
- HH3
-
分子量
- 15.4 kDa
-
基因ID
- 333932
-
途径
- Hedgehog Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
抗原
-
